| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.05 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.089 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |